<i>Gaia</i> Data Release 1. Summary of the astrometric, photometric, and survey properties

Context. At about 1000 days after the launch of Gaia we present the first Gaia data release, Gaia DR1, consisting of astrometry and photometry for over 1 billion sources brighter than magnitude 20.7. Aims. A summary of Gaia DR1 is presented along with illustrations of the scientific quality of the data, followed by a discussion of the limitations due to the preliminary nature of this release. Methods. The raw data collected by Gaia during the first 14 months of the mission have been processed by the Gaia Data Processing and Analysis Consortium (DPAC) and turned into an astrometric and photometric catalogue. Results. Gaia DR1 consists of three components: a primary astrometric data set which contains the positions, parallaxes, and mean proper motions for about 2 million of the brightest stars in common with the HIPPARCOS and Tycho-2 catalogues – a realisation of the Tycho-Gaia Astrometric Solution (TGAS) – and a secondary astrometric data set containing the positions for an additional 1.1 billion sources. The second component is the photometric data set, consisting of mean G-band magnitudes for all sources. The G-band light curves and the characteristics of ∼3000 Cepheid and RR-Lyrae stars, observed at high cadence around the south ecliptic pole, form the third component. For the primary astrometric data set the typical uncertainty is about 0.3 mas for the positions and parallaxes, and about 1 mas yr−1 for the proper motions. A systematic component of ∼0.3 mas should be added to the parallax uncertainties. For the subset of ∼94 000 HIPPARCOS stars in the primary data set, the proper motions are much more precise at about 0.06 mas yr−1. For the secondary astrometric data set, the typical uncertainty of the positions is ∼10 mas. The median uncertainties on the mean G-band magnitudes range from the mmag level to ∼0.03 mag over the magnitude range 5 to 20.7. Conclusions. Gaia DR1 is an important milestone ahead of the next Gaia data release, which will feature five-parameter astrometry for all sources. Extensive validation shows that Gaia DR1 represents a major advance in the mapping of the heavens and the availability of basic stellar data that underpin observational astrophysics. Nevertheless, the very preliminary nature of this first Gaia data release does lead to a number of important limitations to the data quality which should be carefully considered before drawing conclusions from the data

Apathy Associated With Impaired Recognition of Happy Facial Expressions in Huntington's Disease.

OBJECTIVES: Previous research has demonstrated an association between emotion recognition and apathy in several neurological conditions involving fronto-striatal pathology, including Parkinson's disease and brain injury. In line with these findings, we aimed to determine whether apathetic participants with early Huntington's disease (HD) were more impaired on an emotion recognition task compared to non-apathetic participants and healthy controls. METHODS: We included 43 participants from the TRACK-HD study who reported apathy on the Problem Behaviours Assessment - short version (PBA-S), 67 participants who reported no apathy, and 107 controls matched for age, sex, and level of education. During their baseline TRACK-HD visit, participants completed a battery of cognitive and psychological tests including an emotion recognition task, the Hospital Depression and Anxiety Scale (HADS) and were assessed on the PBA-S. RESULTS: Compared to the non-apathetic group and the control group, the apathetic group were impaired on the recognition of happy facial expressions, after controlling for depression symptomology on the HADS and general disease progression (Unified Huntington's Disease Rating Scale total motor score). This was despite no difference between the apathetic and non-apathetic group on overall cognitive functioning assessed by a cognitive composite score. CONCLUSIONS: Impairment of the recognition of happy expressions may be part of the clinical picture of apathy in HD. While shared reliance on frontostriatal pathways may broadly explain associations between emotion recognition and apathy found across several patient groups, further work is needed to determine what relationships exist between recognition of specific emotions, distinct subtypes of apathy and underlying neuropathology. (JINS, 2019, 25, 453-461)

Multi-scale crystallographic ordering in the cold-water coral Lophelia pertusa

Lophelia pertusa is a widespread colonial cold-water coral which can form large three-dimensional habitats for benthic communities. Although it is known to construct an aragonite skeleton with optically opaque and translucent bands, details of its biomineralized structure are unclear. New crystallographic data obtained from Lophelia pertusa using electron backscatter diffraction (EBSD) reveal a remarkably high degree of multiscale self-ordering and provide unprecedented detail on crystallographic orientations within the coral skeleton. The EBSD data unequivocally demonstrate a self-regulated architecture across a range of spatial scales, resulting in a specific structure which contributes to the physical robustness of its skeleton and an evolutionary advantage in such habitats

Changes in the avifauna of Cape York Peninsula over a period of 9 years: the relative effects of fire, vegetation type and climate

An essential component of conservation science is repeated surveys over time to monitor species that might be responding to local factors, such as land management, or more broadly to global change. A systematic survey of the avifauna of Cape York Peninsula was conducted in the late 1990s and early 2000s providing an ideal basal dataset for measuring change in the avifauna. A subset (n > 600) of these sites, primarily within savanna landscapes, was selected for re-survey in 2008 to investigate changes in bird communities on Cape York Peninsula. Changes in mean species richness varied across the study area (decreases in 59 grid cells and increases in 43) with no apparent pattern. Significant change in reporting rates was recorded in 30 species. Four sedentary and highly detectable species declined (Bar-shouldered Dove, Brown Treecreeper, Sulphur-crested Cockatoo and Pale-headed Rosella) and five increased (Peaceful Dove, Pheasant Coucal, Weebill, White-throated Honeyeater and Yellow Oriole). Habitat preference for the species that showed change remained relatively stable between the two survey periods. Some species that were recorded in very low numbers in the original survey and are considered to be threatened (Brown Treecreeper, Black-faced Woodswallow) remained in very low numbers or decreased in our survey suggesting that there has been no regional recovery of these species. Long-term monitoring can describe important patterns of species change over time, though in the case of large, highly seasonal environments like the tropical savannas, signals of change may manifest over decades rather than annually

Two phase 3 trials of adalimumab for hidradenitis suppurativa

BACKGROUND Hidradenitis suppurativa is a painful, chronic inflammatory skin disease with few options for effective treatment. In a phase 2 trial, adalimumab, an antibody against tumor necrosis factor á, showed efficacy against hidradenitis suppurativa. METHODS PIONEER I and II were similarly designed, phase 3 multicenter trials of adalimumab for hidradenitis suppurativa, with two double-blind, placebo-controlled periods. In period 1, patients were randomly assigned in a 1:1 ratio to 40 mg of adalimumab weekly or matching placebo for 12 weeks. In period 2, patients were reassigned to adalimumab at a weekly or every-other-week dose or to placebo for 24 weeks. The primary end point was a clinical response, defined as at least a 50% reduction from baseline in the abscess and inflammatory-nodule count, with no increase in abscess or draining-fistula counts, at week 12. RESULTS We enrolled 307 patients in PIONEER I and 326 in PIONEER II. Clinical response rates at week 12 were significantly higher for the groups receiving adalimumab weekly than for the placebo groups: 41.8% versus 26.0% in PIONEER I (P = 0.003) and 58.9% versus 27.6% in PIONEER II (P&lt;0.001). Patients receiving adalimumab had significantly greater improvement than the placebo groups in rank-ordered secondary outcomes (lesions, pain, and the modified Sartorius score for disease severity) at week 12 in PIONEER II only. Serious adverse events in period 1 (excluding worsening of underlying disease) occurred in 1.3% of patients receiving adalimumab and 1.3% of those receiving placebo in PIONEER I and in 1.8% and 3.7% of patients, respectively, in PIONEER II. In period 2, the rates of serious adverse events were 4.6% or less in all the groups in both studies, with no significant between-group differences. CONCLUSIONS Treatment with adalimumab (40 mg weekly), as compared with placebo, resulted in significantly higher clinical response rates in both trials at 12 weeks; rates of serious adverse events were similar in the study groups. Copyright © 2016 Massachusetts Medical Society. All rights reserved

Representing edge models via local principal component analysis

Abstract. Edge detection depends not only upon the assumed model of what an edge is, but also on how this model is represented. The problem of how to represent the edge model is typically neglected, despite the fact that the representation is a bottleneck for both computational cost and accuracy. We propose to represent edge models by a partition of the edge manifold corresponding to the edge model, where each local element of the partition is described by its principal components. We describe the construction of this representation and demonstrate its benefits for various edge models.